Lower Urinary Tract Symptoms: What’s New in Medical Treatment?

    January 2018 in “ European urology focus
    B. Peyronnet, Benjamin Brucker, Martin C. Michel
    Image of study
    TLDR New drugs and combination therapies are improving treatment for lower urinary tract symptoms.
    The document reviewed emerging evidence in the medical treatment of lower urinary tract symptoms (LUTS). Key innovations included the approval of the first β<sub>3</sub>-adrenoceptor agonists (mirabegron) and intradetrusor onabotulinum toxin A for overactive bladder (OAB). Promising results were seen in phase 3 trials for other drugs like antiepileptics and phosphodiesterase inhibitors. Combination therapies of phosphodiesterase type 5 inhibitors with α-blockers or finasteride were found superior to single therapies. New formulations of desmopressin were approved for nocturia, and fedovapagon completed a large phase 3 trial for nocturia in males. Ongoing phase 3 trials were investigating treatments for bladder pain syndrome and neurogenic detrusor overactivity. The field of medical treatment for LUTS was very active, with several new and emerging drugs under investigation.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Temporary alternative to finasteride?

      in Finasteride  50 upvotes 1 day ago
      A 23-year-old male plans to temporarily stop finasteride to donate plasma for financial reasons and seeks alternative hair loss treatments like minoxidil, ketoconazole, or RU58841 during this period. He is open to suggestions to prevent further hair loss until he can resume finasteride.

      community Sensitive liver, topical fin safe to try?

      in Finasteride  98 upvotes 5 days ago
      Topical finasteride is considered safer for the liver than oral finasteride due to less systemic absorption, but regular liver function tests are advised. The user is concerned about liver health due to a history of NAFLD and is exploring topical finasteride as a safer alternative.

      community 8 months Fin + Oral Minox - still losing some hairs, normal?

      in Finasteride  90 upvotes 1 week ago
      After 8 months of using oral Minoxidil 5mg and Finasteride 1mg, the user still experiences hair loss, particularly miniaturized hairs in the mid-scalp area, along with itching. They are concerned about losing around 40 hairs daily despite treatment.

      community Finasteride - discomfort pelvir/urethra

      in Finasteride  79 upvotes 1 week ago
      Finasteride can cause pelvic or urethral discomfort for some users. Reducing the dose to 0.25 mg on Mondays, Wednesdays, and Fridays is being considered as a potential solution.

    Related Research

    1 / 1 results